Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Oct 1;319(Pt 1):117–122. doi: 10.1042/bj3190117

Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants.

P H van Berkel 1, H A van Veen 1, M E Geerts 1, H A de Boer 1, J H Nuijens 1
PMCID: PMC1217743  PMID: 8870657

Abstract

Human lactoferrin (hLF) is a glycoprotein involved in the host defence against infection and excessive inflammation. Our objective was to determine to what extent each of the three sequons for N-linked glycosylation in hLF is actually used. Human kidney-derived 293(S) cell lines expressing recombinant hLF (rhLF) or glycosylation-site mutants were produced. The mutations involved replacement of asparagine residues with glutamine at one or more sequons for N-glycosylation (Asn138, Asn479 and Asn624). Comparative SDS/PAGE analyses of rhLF, mutated rhLF and human-milk-derived (natural) hLF led us to propose that glycosylation of hLF occurs at two sites (at Asn138 and Asn479) in approx. 85% of all hLF molecules. Glycosylation at a single site (Asn479) or at all three sites occurs in approx, 5% and 9% of hLF respectively. The extent of glycosylation at Asn624 was increased to approx. 29% and 40% of Asn479 and Asn138/479 mutant molecules respectively, which indicates that glycosylation at Asn624 in natural hLF might be limited by glycosylation at Asn479. The presence in supernatant of unglycosylated hLF (approx. 60% of the total) after mutations of Asn138 and Asn479 suggests that glycosylation of hLF is not an absolute requirement for its secretion. The pronounced degradation of unglycosylated hLF in supernatant after mutation at all three glycosylation sites (Asn138/479/624 mutant) but not after mutation at both Asn138 and Asn479 suggests that an altered conformation rather than the lack of glycosylation has rendered the Asn138/479/624 mutant susceptible to intra- and/or extra-cellular degradation.

Full Text

The Full Text of this article is available as a PDF (357.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alcantara J., Padda J. S., Schryvers A. B. The N-linked oligosaccharides of human lactoferrin are not required for binding to bacterial lactoferrin receptors. Can J Microbiol. 1992 Nov;38(11):1202–1205. doi: 10.1139/m92-198. [DOI] [PubMed] [Google Scholar]
  2. Allen S., Naim H. Y., Bulleid N. J. Intracellular folding of tissue-type plasminogen activator. Effects of disulfide bond formation on N-linked glycosylation and secretion. J Biol Chem. 1995 Mar 3;270(9):4797–4804. doi: 10.1074/jbc.270.9.4797. [DOI] [PubMed] [Google Scholar]
  3. Anderson B. F., Baker H. M., Norris G. E., Rice D. W., Baker E. N. Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 A resolution. J Mol Biol. 1989 Oct 20;209(4):711–734. doi: 10.1016/0022-2836(89)90602-5. [DOI] [PubMed] [Google Scholar]
  4. Anderson B. F., Baker H. M., Norris G. E., Rumball S. V., Baker E. N. Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins. Nature. 1990 Apr 19;344(6268):784–787. doi: 10.1038/344784a0. [DOI] [PubMed] [Google Scholar]
  5. Appelmelk B. J., An Y. Q., Geerts M., Thijs B. G., de Boer H. A., MacLaren D. M., de Graaff J., Nuijens J. H. Lactoferrin is a lipid A-binding protein. Infect Immun. 1994 Jun;62(6):2628–2632. doi: 10.1128/iai.62.6.2628-2632.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Argos P. Analysis of sequence-similar pentapeptides in unrelated protein tertiary structures. Strategies for protein folding and a guide for site-directed mutagenesis. J Mol Biol. 1987 Sep 20;197(2):331–348. doi: 10.1016/0022-2836(87)90127-6. [DOI] [PubMed] [Google Scholar]
  7. Arnold R. R., Cole M. F., McGhee J. R. A bactericidal effect for human lactoferrin. Science. 1977 Jul 15;197(4300):263–265. doi: 10.1126/science.327545. [DOI] [PubMed] [Google Scholar]
  8. Britigan B. E., Hassett D. J., Rosen G. M., Hamill D. R., Cohen M. S. Neutrophil degranulation inhibits potential hydroxyl-radical formation. Relative impact of myeloperoxidase and lactoferrin release on hydroxyl-radical production by iron-supplemented neutrophils assessed by spin-trapping techniques. Biochem J. 1989 Dec 1;264(2):447–455. doi: 10.1042/bj2640447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Crouch S. P., Slater K. J., Fletcher J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood. 1992 Jul 1;80(1):235–240. [PubMed] [Google Scholar]
  10. Deng W. P., Nickoloff J. A. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal Biochem. 1992 Jan;200(1):81–88. doi: 10.1016/0003-2697(92)90280-k. [DOI] [PubMed] [Google Scholar]
  11. Derisbourg P., Wieruszeski J. M., Montreuil J., Spik G. Primary structure of glycans isolated from human leucocyte lactotransferrin. Absence of fucose residues questions the proposed mechanism of hyposideraemia. Biochem J. 1990 Aug 1;269(3):821–825. doi: 10.1042/bj2690821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grinnell B. W., Walls J. D., Gerlitz B. Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin. J Biol Chem. 1991 May 25;266(15):9778–9785. [PubMed] [Google Scholar]
  13. Hasegawa M., Orita T., Kojima T., Tomonoh K., Hirata Y., Ochi N. Improvement in the heterogeneous N-termini and the defective N-glycosylation of human interleukin-6 by genetic engineering. Eur J Biochem. 1992 Nov 15;210(1):9–12. doi: 10.1111/j.1432-1033.1992.tb17384.x. [DOI] [PubMed] [Google Scholar]
  14. Imber M. J., Pizzo S. V. Clearance and binding of native and defucosylated lactoferrin. Biochem J. 1983 May 15;212(2):249–257. doi: 10.1042/bj2120249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kasturi L., Eshleman J. R., Wunner W. H., Shakin-Eshleman S. H. The hydroxy amino acid in an Asn-X-Ser/Thr sequon can influence N-linked core glycosylation efficiency and the level of expression of a cell surface glycoprotein. J Biol Chem. 1995 Jun 16;270(24):14756–14761. doi: 10.1074/jbc.270.24.14756. [DOI] [PubMed] [Google Scholar]
  16. Kawakami H., Lönnerdal B. Isolation and function of a receptor for human lactoferrin in human fetal intestinal brush-border membranes. Am J Physiol. 1991 Nov;261(5 Pt 1):G841–G846. doi: 10.1152/ajpgi.1991.261.5.G841. [DOI] [PubMed] [Google Scholar]
  17. Kijlstra A., Jeurissen S. H. Modulation of classical C3 convertase of complement by tear lactoferrin. Immunology. 1982 Oct;47(2):263–270. [PMC free article] [PubMed] [Google Scholar]
  18. Konings R. N., Luiten R. G., Peeters B. P. Mike, a chimeric filamentous phage designed for the separate production of either DNA strand of pKUN vector plasmids by F+ cells. Gene. 1986;46(2-3):269–276. doi: 10.1016/0378-1119(86)90411-7. [DOI] [PubMed] [Google Scholar]
  19. Kunkel T. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A. 1985 Jan;82(2):488–492. doi: 10.1073/pnas.82.2.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Legrand D., Mazurier J., Colavizza D., Montreuil J., Spik G. Properties of the iron-binding site of the N-terminal lobe of human and bovine lactotransferrins. Importance of the glycan moiety and of the non-covalent interactions between the N- and C-terminal lobes in the stability of the iron-binding site. Biochem J. 1990 Mar 1;266(2):575–581. [PMC free article] [PubMed] [Google Scholar]
  21. Legrand D., Salmon V., Coddeville B., Benaissa M., Plancke Y., Spik G. Structural determination of two N-linked glycans isolated from recombinant human lactoferrin expressed in BHK cells. FEBS Lett. 1995 May 22;365(1):57–60. doi: 10.1016/0014-5793(95)00441-b. [DOI] [PubMed] [Google Scholar]
  22. McClure D. B., Walls J. D., Grinnell B. W. Post-translational processing events in the secretion pathway of human protein C, a complex vitamin K-dependent antithrombotic factor. J Biol Chem. 1992 Sep 25;267(27):19710–19717. [PubMed] [Google Scholar]
  23. Nakai K., Kanehisa M. Prediction of in-vivo modification sites of proteins from their primary structures. J Biochem. 1988 Nov;104(5):693–699. doi: 10.1093/oxfordjournals.jbchem.a122535. [DOI] [PubMed] [Google Scholar]
  24. Nuijens J. H., Abbink J. J., Wachtfogel Y. T., Colman R. W., Eerenberg A. J., Dors D., Kamp A. J., Strack van Schijndel R. J., Thijs L. G., Hack C. E. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med. 1992 Feb;119(2):159–168. [PubMed] [Google Scholar]
  25. Opdenakker G., Rudd P. M., Ponting C. P., Dwek R. A. Concepts and principles of glycobiology. FASEB J. 1993 Nov;7(14):1330–1337. doi: 10.1096/fasebj.7.14.8224606. [DOI] [PubMed] [Google Scholar]
  26. Panella T. J., Liu Y. H., Huang A. T., Teng C. T. Polymorphism and altered methylation of the lactoferrin gene in normal leukocytes, leukemic cells, and breast cancer. Cancer Res. 1991 Jun 1;51(11):3037–3043. [PubMed] [Google Scholar]
  27. Parekh R. B., Tse A. G., Dwek R. A., Williams A. F., Rademacher T. W. Tissue-specific N-glycosylation, site-specific oligosaccharide patterns and lentil lectin recognition of rat Thy-1. EMBO J. 1987 May;6(5):1233–1244. doi: 10.1002/j.1460-2075.1987.tb02359.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Platenburg G. J., Kootwijk E. P., Kooiman P. M., Woloshuk S. L., Nuijens J. H., Krimpenfort P. J., Pieper F. R., de Boer H. A., Strijker R. Expression of human lactoferrin in milk of transgenic mice. Transgenic Res. 1994 Mar;3(2):99–108. doi: 10.1007/BF01974087. [DOI] [PubMed] [Google Scholar]
  29. Powell M. J., Ogden J. E. Nucleotide sequence of human lactoferrin cDNA. Nucleic Acids Res. 1990 Jul 11;18(13):4013–4013. doi: 10.1093/nar/18.13.4013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Reiter B., Brock J. H., Steel E. D. Inhibition of Escherichia coli by bovine colostrum and post-colostral milk. II. The bacteriostatic effect of lactoferrin on a serum susceptible and serum resistant strain of E. coli. Immunology. 1975 Jan;28(1):83–95. [PMC free article] [PubMed] [Google Scholar]
  31. Rey M. W., Woloshuk S. L., deBoer H. A., Pieper F. R. Complete nucleotide sequence of human mammary gland lactoferrin. Nucleic Acids Res. 1990 Sep 11;18(17):5288–5288. doi: 10.1093/nar/18.17.5288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sato T., Takio K., Kobata A., Greenwalt D. E., Furukawa K. Site-specific glycosylation of bovine butyrophilin. J Biochem. 1995 Jan;117(1):147–157. doi: 10.1093/oxfordjournals.jbchem.a124702. [DOI] [PubMed] [Google Scholar]
  33. Savvidou G., Klein M., Grey A. A., Dorrington K. J., Carver J. P. Possible role for peptide-oligosaccharide interactions in differential oligosaccharide processing at asparagine-107 of the light chain and asparagine-297 of the heavy chain in a monoclonal IgG1 kappa. Biochemistry. 1984 Jul 31;23(16):3736–3740. doi: 10.1021/bi00311a026. [DOI] [PubMed] [Google Scholar]
  34. Spik G., Coddeville B., Montreuil J. Comparative study of the primary structures of sero-, lacto- and ovotransferrin glycans from different species. Biochimie. 1988 Nov;70(11):1459–1469. doi: 10.1016/0300-9084(88)90283-0. [DOI] [PubMed] [Google Scholar]
  35. Spik G., Strecker G., Fournet B., Bouquelet S., Montreuil J., Dorland L., van Halbeek H., Vliegenthart J. F. Primary structure of the glycans from human lactotransferrin. Eur J Biochem. 1982 Jan;121(2):413–419. doi: 10.1111/j.1432-1033.1982.tb05803.x. [DOI] [PubMed] [Google Scholar]
  36. Sánchez L., Calvo M., Brock J. H. Biological role of lactoferrin. Arch Dis Child. 1992 May;67(5):657–661. doi: 10.1136/adc.67.5.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Ward P. P., Piddington C. S., Cunningham G. A., Zhou X., Wyatt R. D., Conneely O. M. A system for production of commercial quantities of human lactoferrin: a broad spectrum natural antibiotic. Biotechnology (N Y) 1995 May;13(5):498–503. doi: 10.1038/nbt0595-498. [DOI] [PubMed] [Google Scholar]
  39. van Berkel P. H., Geerts M. E., van Veen H. A., Kooiman P. M., Pieper F. R., de Boer H. A., Nuijens J. H. Glycosylated and unglycosylated human lactoferrins both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibilities towards tryptic proteolysis. Biochem J. 1995 Nov 15;312(Pt 1):107–114. doi: 10.1042/bj3120107. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES